206 related articles for article (PubMed ID: 1675867)
1. A comparison of the chronic effects of oral xamoterol and enalapril on blood pressure and renal function in mild to moderate heart failure.
Jamieson MJ; Webster J; Fowler G; Rawles J; Smith FW; Petrie JC
Br J Clin Pharmacol; 1991 Mar; 31(3):305-12. PubMed ID: 1675867
[TBL] [Abstract][Full Text] [Related]
2. Lack of tolerance development after long-term administration of the partial beta-adrenoceptor agonist xamoterol.
Erlemeier HH; Kupper W; Bleifeld W
Cardiology; 1990; 77(1):30-9. PubMed ID: 1972349
[TBL] [Abstract][Full Text] [Related]
3. The acute effects of intravenous xamoterol ('Corwin', I.C.I. 118, 587) on resting and exercise haemodynamics in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Sadler AM; Smith SJ; Nuttall A; Murray RG; Littler WA; Davies MK
Eur Heart J; 1989 Mar; 10(3):227-34. PubMed ID: 2565233
[TBL] [Abstract][Full Text] [Related]
4. Xamoterol in severe congestive heart failure: long-term oral treatment, a double-blind randomised study.
Tangø M; Lyngborg K; Mehlsen J; Svendsen TL; Trap-Jensen J
Int J Cardiol; 1992 Jan; 34(1):63-8. PubMed ID: 1347763
[TBL] [Abstract][Full Text] [Related]
5. Effects of xamoterol on resting and exercise haemodynamics in patients with chronic heart failure.
Virk SJ; Davies MK
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):15S-22S. PubMed ID: 2572250
[TBL] [Abstract][Full Text] [Related]
6. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
[TBL] [Abstract][Full Text] [Related]
7. Acute and chronic hemodynamic effects of xamoterol in mild to moderate congestive heart failure.
Virk SJ; Qiang FX; Anfilogoff NH; Murray RG; Littler WA; Davies MK
Am J Cardiol; 1991 May; 67(12):48C-52C; discussion 52C-54C. PubMed ID: 1673587
[TBL] [Abstract][Full Text] [Related]
8. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
[TBL] [Abstract][Full Text] [Related]
9. Effects of captopril and enalapril on renal function in elderly patients with chronic heart failure.
Haffner CA; Kendall MJ; Struthers AD; Bridges A; Stott DJ
Postgrad Med J; 1995 May; 71(835):287-92. PubMed ID: 7596934
[TBL] [Abstract][Full Text] [Related]
10. The cardiovascular effects of xamoterol, a beta 1-adrenoceptor partial agonist, in healthy volunteers at rest.
Hashimoto T; Shiina A; Toyo-Oka T; Hosoda S; Kondo K
Br J Clin Pharmacol; 1986 Mar; 21(3):259-65. PubMed ID: 2421751
[TBL] [Abstract][Full Text] [Related]
11. The effect of oral dosing of xamoterol on systolic time intervals in man and xamoterol plasma concentrations in heart failure patients.
James MA; Papouchado M; Channer KS; Jones JV; Marlow HF; Bastain W; Barker NP; Harry JD; Wardleworth AG
Br J Clin Pharmacol; 1990 Apr; 29(4):447-53. PubMed ID: 2139340
[TBL] [Abstract][Full Text] [Related]
12. Renal and systemic effects of enalapril in chronic one-kidney hypertension.
Woods RL; Anderson WP; Korner PI
Hypertension; 1986 Feb; 8(2):109-16. PubMed ID: 3002979
[TBL] [Abstract][Full Text] [Related]
13. Immediate central and regional haemodynamic effects of a new beta 1-adrenergic stimulating drug, xamoterol (Corwin) in healthy volunteers.
Tangø M; Carlsen JE; Trap-Jensen J
Eur J Clin Pharmacol; 1985; 29(2):155-8. PubMed ID: 2866963
[TBL] [Abstract][Full Text] [Related]
14. Effects of xamoterol on sodium excretion in volunteers.
Zech PY; Pozet N; Day MA; Snow HM; Madonna O; Hadj-Aissa A
Br J Clin Pharmacol; 1989; 28 Suppl 1(Suppl 1):89S-91S. PubMed ID: 2572266
[TBL] [Abstract][Full Text] [Related]
15. The effects of the partial beta 1-agonist xamoterol on heart rate and ventricular arrhythmias in patients with mild to moderate heart failure.
Virk SJ; Anfilogoff NH; Lawson N; Qiang F; Murray RG; Littler WA; Davies MK
Eur Heart J; 1990 Oct; 11(10):876-84. PubMed ID: 1979946
[TBL] [Abstract][Full Text] [Related]
16. [Noninvasive evaluation of partial beta adrenergic agonist properties of xamoterol in cardiac insufficiency].
Richaud M; Lechat P; Komajda M; Landault C; Fournier P; Fraysse JB; Grosgogeat Y
Arch Mal Coeur Vaiss; 1990 Feb; 83(2):247-52. PubMed ID: 1968739
[TBL] [Abstract][Full Text] [Related]
17. Xamoterol in severe heart failure. The Xamoterol in Severe Heart Failure Study Group.
Lancet; 1990 Jul; 336(8706):1-6. PubMed ID: 1694945
[TBL] [Abstract][Full Text] [Related]
18. Effect of additive renin inhibition with aliskiren on renal blood flow in patients with Chronic Heart Failure and Renal Dysfunction (Additive Renin Inhibition with Aliskiren on renal blood flow and Neurohormonal Activation in patients with Chronic Heart Failure and Renal Dysfunction).
Schroten NF; Damman K; Hemmelder MH; Voors AA; Navis G; Gaillard CA; van Veldhuisen DJ; Van Gilst WH; Hillege HL
Am Heart J; 2015 May; 169(5):693-701.e3. PubMed ID: 25965717
[TBL] [Abstract][Full Text] [Related]
19. Effect of xamoterol on haemodynamics and plasma catecholamines in chronic heart failure.
Ollivier JP; Ricordei I; Bayon P; Popelard P; Moyse D; de Bourayne J; Dupont C; Droniou J
Eur Heart J; 1990 Apr; 11 Suppl A():59-60. PubMed ID: 1971594
[TBL] [Abstract][Full Text] [Related]
20. Double-blind placebo-controlled comparison of digoxin and xamoterol in chronic heart failure. The German and Austrian Xamoterol Study Group.
Lancet; 1988 Mar; 1(8584):489-93. PubMed ID: 2893916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
